Institute Medical Microbiology, University Zurich, Gloriastr 30, 8006 Zurich, Switzerland.
Max Planck Institute for Molecular Genetics, Ihnestr 73, 14195 Berlin, Germany.
Viruses. 2021 Apr 25;13(5):751. doi: 10.3390/v13050751.
Some of the newly emerging corona viral variants show high numbers of mutations. This is unexpected for a virus with a low mutation rate due to an inherent proof-reading system. Could such a variant arise under very special conditions occurring in a host where the virus replicates and mutates in a rather unlimited fashion, such as in immune compromised patients? The virus was shown to replicate in an immunosuppressed cancer patient for more than 105 days and might be a source of new variants. These patients are asymptomatic and the virus may therefore escape detection and attention and be high-risk. Similarly, HIV-infected individuals may be immunocompromised and support coronavirus replication with increased mutation rates. The patients may promote "within-host evolution". Some of the viruses present in such a highly mutagenic swarm or quasispecies within one patient may become founders and cause a pandemic by further "between-host evolution". B.1.1.7 with 23 mutations may be such a case. Immunosuppressed patients can be identified and treated by the synthetic antibody cocktails as passive immunization and kept under control. Immunosuppressed patients can be easily identified and supervised by healthcare workers-once they become aware of the risk-to avoid new variants with pandemic potential.
一些新出现的冠状病毒变种显示出大量的突变。对于一个由于固有校对系统而突变率较低的病毒来说,这是出乎意料的。在宿主中,病毒以相当无限的方式复制和突变的非常特殊的条件下,是否会出现这样的变异体?病毒在免疫抑制的癌症患者中复制超过 105 天,可能是新变种的来源。这些患者无症状,因此病毒可能逃避检测和关注,成为高风险因素。同样,感染 HIV 的个体可能免疫功能低下,支持冠状病毒以更高的突变率复制。患者可能会促进“体内进化”。在一个患者体内如此高突变的病毒群或准种中存在的一些病毒可能成为创始人,并通过进一步的“种间进化”引发大流行。具有 23 种突变的 B.1.1.7 可能就是这种情况。可以通过合成抗体鸡尾酒作为被动免疫来识别和治疗免疫抑制患者,并进行控制。免疫抑制患者可以通过医护人员轻松识别和监督——一旦他们意识到风险,就可以避免具有大流行潜力的新变种。